Effect of metoprolol on quality of life in the prevention of syncope trial

Journal of Cardiovascular Electrophysiology

Volumn 20, Issue 10, 2009, Pages 1083-1088

  Sheldon, Robert S ^a   Amuah, Joseph E ^a   Connolly, Stuart J ^b   Rose, Sarah ^a   Morillo, Carlos A ^b   Talajic, Mario ^e   Kus, Teresa ^e   Fouad Tarazi, Fetnat ^f   Klingenheben, Thomas ^c   Krahn, Andrew D ^d   Koshman, Mary Lou ^a   Ritchie, Debbie ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c GOETHE UNIVERSITY   (Germany)

^d UNIVERSITY OF WESTERN ONTARIO   (Canada)

^e UNIVERSITÉ DE MONTRÉAL   (Canada)

^f LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Beta blockers; Quality of life; Randomized trial; Tilt test; Vasovagal syncope

Indexed keywords

METOPROLOL; PLACEBO;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SYNCOPE; TILT TABLE TEST;

ADULT; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INTERNATIONALITY; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PREVALENCE; QUALITY OF LIFE; QUESTIONNAIRES; RISK ASSESSMENT; RISK FACTORS; SYNCOPE, VASOVAGAL; TREATMENT OUTCOME;

EID: 70350518056     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/j.1540-8167.2009.01518.x     Document Type: Article

References (25)

1. Linzer M, Pontinen M, Gold DT, Divine GW, Felder A, Brooks WB : Impairment of physical and psychosocial function in recurrent syncope. J Clin Epidemiol 1991 44 : 1037 1043.
2. Rose S, Koshman ML, Spreng S, Sheldon RS : The relationship between health-related quality of life and frequency of spells in patients with syncope. J Clin Epi 2000 53 : 1209 1216.
3. Van Dijk N, Sprangers MA, Colman N, Boer KR, Wieling W, Linzer M : Clinical factors associated with quality pf life in patients with transient loss of consciousness. J Cardiovasc Electrophysiol 2006 17 : 998 1003.
4. Van Dijk N, Sprangers MA, Boer KR, Colman N, Wieling W, Linzer M : Quality of life within one year following presentation after transient loss of consciousness. Am J Cardiol 2007 100 : 672 676.
5. Van Dijk N, Boer KR, Wieling W, Linzer M, Sprangers MA : Reliability, validity and responsiveness of the syncope functional status questionnaire. J Gen Intern Med 2007 22 : 1280 1285.
6. Cox MM, Perlman BA, Mayor MR, Silberstein TA, Levin E, Pringle L, Castellanos A, Myerburg R : Acute and long-term beta-adrenergic blockade for patients with neurocardiogenic syncope. J Am Coll Cardiol 1995 26 : 1293 1298.
7. Sheldon RS, Rose S, Flanagan P, Koshman ML, Killam S : Effect of beta-blockers on the time to first syncope recurrence in patients after a positive isoproterenol-tilt table test. Am J Cardiol 1996 78 : 536 539.
8. Alegria JR, Gersh BJ, Scott CG, Hodge DO, Hammill SC, Shen WK : Comparison of frequency of recurrent syncope after beta-blocker therapy versus conservative management for patients with vasovagal syncope. Am J Cardiol 2003 92 : 82 84.
9. Mahanonda N, Bhuripanyo K, Kangkagate C, Wansanit K, Kulchot B, Nademanee K, Chaithiraphan S : Randomized double-blind, placebo-controlled trial of oral atenolol in patients with unexplained syncope and positive upright tilt table test results. Am Heart J 1995 130 : 1250 1253.
10. Madrid AH, Ortega J, Rebollo JG, Manzano JG, Segovia JG, Sanchez A, Pena G, Moro C : Lack of efficacy of atenolol for the prevention of neurally mediated syncope in a highly symptomatic population: A prospective, double-blind, randomized and placebo-controlled study. J Am Coll Cardiol 2001 37 : 554 559.
11. Flevari P, Livanis EG, Theodorakis GN, Zarvalis E, Mesiskli T, Kremastinos DT : Vasovagal syncope: A prospective, randomized, crossover evaluation of the effect of propranolol, nadolol and placebo on syncope recurrence and patients' well-being. J Am Coll Cardiol 2002 40 : 499 504.
12. Ventura R, Maas R, Zeidler D, Schoder V, Nienaber CA, Schuchert A, Meinertz T : A randomized and controlled pilot trial of beta-blockers for the treatment of recurrent syncope in patients with a positive or negative response to head-up tilt test. Pacing Clin Electrophysiol 2002 25 : 816 821.
13. Natale A, Newby KH, Dhala A, Akhtar M, Sra J : Response to beta blockers in patients with neurocardiogenic syncope: How to predict beneficial effects. J Cardiovasc Electrophysiol 1996 7 : 1154 1158.
14. Leor J, Rotstein Z, Vered Z, Kaplinsky E, Truman S, Eldar M : Absence of tachycardia during tilt test predicts failure of beta-blocker therapy in patients with neurocardiogenic syncope. Am Heart J 1994 127 : 1539 1543.
15. Sheldon RS, Connolly S, Rose S, Klingenheben T, Krahn A, Morillo C, Talajic M, Kus T, Fouad-Tarazi F, Ritchie D, Koshman ML : The Prevention of Syncope Trial (POST): A randomized, placebo-controlled study of metoprolol in the prevention of vasovagal syncope. Circulation 2006 113 : 1164 1170.
16. Sheldon R, Koshman ML, Wilson W, Kieser T, Rose S : Effect of dual chamber pacing with automatic rate-drop sensing on recurrent neurally mediated syncope. Am J Cardiol 1988 81 : 158 162.
17. Ware JE, Snow KK, Kosinski M, Gandek B : SF-36 Health Survey Manual and Interpretation Guide. Boston, MA : The Health Institute, New England Medical Center, 1993.
18. Dolan P : Modeling valuations for EuroQol health states. Med Care 1997 35 : 1095 1108.
19. Van Dijk N, Boer KR, Colman N, Bakker A, Stam J, Van Grieken JM, Wilde AAM, Linzer M, Reitsma JB, Wieling W : High diagnostic yield and accuracy of history, physical examination, and ECG in patients with transient loss of consciousness in FAST: The fainting assessment study. J Cardiovasc Electrophysiol 2008 19 : 48 55.
20. Dendi R, Goldstein DS : Meta-analysis of nonselective versus beta-1 adrenoceptor-selective blockade in prevention of tilt-induced neurocardiogenic syncope. Am J Cardiol 2002 89 : 1319 1321.
21. Sheldon RS, Rose S, Koshman ML : Comparison of patients with syncope of unknown cause having negative or positive tilt table tests. Am J Cardiol 1997 80 : 581 585.
22. Grimm W, Degenhardt M, Hoffmann J, Menz V, Wirths A, Maisch B : Syncope recurrence can be better predicted by history than by head-up tilt testing in untreated patients with suspected neurally mediated syncope. Eur Heart J 1997 18 : 1465 1469.
23. Moya A, Brignole M, Menozzi C, Garcia-Civera R, Tognarini S, Mont L, Botto G, Giada F, Cornacchia D : Mechanism of syncope in patients with isolated syncope and in patients with tilt-positive syncope. Circulation 2001 104 : 1261 1267. (Pubitemid 32848115)
24. Hopman WA, Towheed T, Anastassiades T, Tenenhouse A, Poliquin S, Berger C, Joseph L, Brown JP, Murray TM, Adachi JD, Hanley DA, Papadimitropoulos E : Canadian normative data for the SF-36 health survey. CMAJ 2000 163 : 265 271.
25. Ware JE, Gandek B, Kosinski M Aaronson NK, Apolone G, Brazier J, Bullinger M, Kaasa S, Leplege A, Prieto L, Sullivan M, Thunedborg K : The equivalence of SF-36 summary health scores estimated using standard and country-specific algorithms in 10 countries: Results from the IQOLA project. J Clin Epidemiol 1998 51 : 1167 1170.